Update on chemotherapy of renal tuberculosis.

A 5-year experience is presented with a new regimen for renal tuberculosis, consisting of isoniazid, ethambutol and rifampin. This regimen has proved satisfactory to date and compares favorably to previous regimens. A plea for long-term therapy is made until further study of short-term treatment proves it to be free of recurrences.